Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Wound
Interventions
DEVICE

Sodium Hyaluronate Lyophilizate

Device is placed directly onto the treated wound. The wound should be cleaned with antiseptic solution prior to the device administration. The device is fixed on the wound by secondary dressing: e.g. plaster, compression.

Trial Locations (4)

Unknown

Fakultni nemocnice u sv. Anny, Brno

Levitovo centrum nasledne pece, Hořice

Vojenska nemocnice Olomouc, Olomouc

Vsetinska nemocnice, Vsetín

Sponsors
All Listed Sponsors
lead

Contipro Pharma a.s.

OTHER

NCT05618496 - Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients | Biotech Hunter | Biotech Hunter